Drugmakers Move To Dismiss Case Claiming Sickle Cell Medication Was Ineffective
SAN FRANCISCO — An amended complaint filed by seven individuals who allege that Oxbryta (voxelotor), a prescription medication used for the treatment of sickle cell disease (SCD), was ineffective should be...To view the full article, register now.
Already a subscriber? Click here to view full article